Singh jay k (57 Ergebnisse)

Zustand: New.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New.

Paperback. Zustand: New.

Paperback. Zustand: New.

Zustand: New.

Zustand: New. In English.

Zustand: As New. Unread book in perfect condition.

paperback. Zustand: New. Brand new book, sourced directly from publisher. Dispatch time is 7-8 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

Taschenbuch. Zustand: Neu. Neuware - This book is broadly focused on recent developments in nanotechnology and artificial intelligence-based drug delivery systems, diagnosis, and the role of various nanomaterials in the management of gastrointestinal diseases, such as abdominal pain, bowel obstruction, diarrhoea, pancreatitis, celiac disease, intestinal tuberculosis and stomach cancer. It's hoped that this work will provide a comprehensive resource for clinicians, scientists, and researchers in a variety of fields such as gastroenterology, biotechnology, nanotechnology, pharmaceutical biotechnology, pharmacology, pharmaceuticals, nanomedicine, tissue engineering and biomaterials.Key Features: - Book will explain how the most recent advances in applications of novel biomaterials, nanotechnology and artificial intelligence have paved the way for new breakthroughs in drug delivery related to gastrointestinal diseases. - It will cover in detail how AI and nanotechnology are working together to solve real-world clinical issues in gastroenterology. - Covers how nanotechnology is enhancing the specificity of detection and reducing the toxicity of drugs in the diagnosis and treatment of GI diseases. - Explores the emerging technology of AI in endoscopic analysis of inflammatory lesions and stomach cancer. - Explains how AI based nanomedicine can control molecules to make devices with pre-programmed functionality for more accurate drug delivery.…

Paperback. Zustand: New.

Zustand: New.

Zustand: New.

Zustand: New.

Paperback. Zustand: New. In shrink wrap. Looks like an interesting title.

Zustand: As New. Unread book in perfect condition.

Zustand: New.

Paperback. Zustand: New.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Zustand: Brand New. 380 pages. 9.18x6.12x9.21 inches. In Stock.

Zustand: New. In English.

hardcover. Zustand: Fine.

Zustand: New.

Zustand: New.

Hardcover. Zustand: New. Brand new book, sourced directly from publisher. Dispatch time is 7-8 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book explores the potential of nanotechnology in treating metabolic disorders, highlighting its potential to improve drug delivery, early disease detection, and precision therapeutics. Metabolic syndrome is a significant global health challenge, with a five-fld increase in the risk of developing type-2 diabetes and a two-fold heightened risk of cardiovascular diseases. Despite advancements in understanding the pathogenesis of metabolic syndrome, current therapeutic interventions have not achieved optimal efficacy. The integration of nanotechnology into biomedicine is seen as a promising avenue to address this issue.Nanoparticles can be engineered to carry anti-inflammatory agents, providing targeted relief at inflammation sites, reducing inflammation and minimizing systemic side effects. Nanotechnology also enhances drug delivery systems by navigating biological barriers and reaching specific sites with precision. This not only improves the bioavailability of therapeutic agents but also minimizes off-target effects, enhancing overall treatment effectiveness.Nanotechnology also plays a pivotal role in early disease detection and diagnosis through innovative nano-imaging techniques. These techniques enable the visualization of molecular and cellular events at unprecedented resolutions, facilitating the identification of metabolic syndrome markers and associated disorders at their incipient stages. As research progresses, the integration of nanotechnology has the potential to redefine metabolic syndrome management, offering hope for improved patient outcomes and a healthier global population.The chapters cover metabolic syndromes, including insulin resistance, hypertension, dyslipidemia, type 2 diabetes, obesity, inflammation, and non-alcoholic fatty liver disease. It provides up-to-date literature on mechanistic understanding and therapeutic strategies. It is a valuable resource for UG/PG students, clinicians, academicians, scientists, researchers, and industrial specialists in advanced materials science, flexible electronics, nanoelectronics, energy, environmental, and biomedical sciences.…

Zustand: New.

Zustand: New.